Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacotherapeutics III > Exam 3 - Asthma/COPD > Flashcards

Exam 3 - Asthma/COPD Flashcards

1
Q

intermittent asthma (0-4 yrs)

A

symptoms = 2 days/week
0 night time awakenings
SABA use = 2 days/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

intermittent asthma (5-11 yrs)

A

symptoms = 2 days/week
= 2 nighttime awakenings/week
SABA use = 2 days/week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

mild asthma (0-4 yrs)

A

symptoms > 2 days/week (not daily)
1-2 nighttime awakenings/month
SABA use > 2 days/week (not daily)
minor normal activity limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mild asthma (5-11 yrs)

A

symptoms > 2 days/week (not daily)
3-4 nighttime awakenings/month
SABA use > 2 days/week (not daily)
minor normal activity limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

moderate asthma (0-4 yrs)

A

symptoms daily
3-4 nighttime awakenings/month
SABA use daily
some normal activity limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

moderate asthma (5-11 yrs)

A

symptoms daily
> 1 nighttime awakening per week (not nightly)
SABA use daily
some normal activity limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

severe asthma (0-4 yrs)

A

symptoms throughout the day
> 1 nighttime awakening/week
SABA use several times per day
extreme normal activity limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

severe asthma (5-11 yrs)

A

symptoms throughout the day
nighttime awakenings often (7/week)
SABA use several times per day
extreme normal activity limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

step 1 therapy (0-4 yrs)

A

SABA prn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

step 2 therapy (0-4 yrs)

A

preferred:
low-dose ICS

alternative:
montelukast or cromolyn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

step 3 therapy (0-4 yrs)

A

medium dose ICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

step 4 therapy (0-4 yrs)

A

medium-dose ICS
AND
montelukast or LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

step 5 therapy (0-4 yrs)

A

high-dose ICS
AND
montelukast or LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

step 6 therapy (0-4 yrs)

A 
high-dose ICS
AND
montelukast or LABA
AND
oral coricosteroids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

step 1 therapy (5-11 yrs)

A

SABA prn

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

step 2 therapy (5-11 yrs)

A

preferred:
low-dose ICS

alternative:
LTRA, cromolyn, OR nedocromil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

step 3 therapy (5-11 yrs)

A

preferred:
medium-dose ICS
OR
low-dose ICS + LABA, LTRA, or theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

step 4 therapy (5-11 yrs)

A

preferred:
medium dose ICS + LABA

alternative:
medium-dose ICS + LTRA or theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

step 5 therapy (5-11 yrs)

A

preferred:
high-dose ICS + LABA

alternative:
high-dose ICS + LTRA or theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

step 6 therapy (5-11 yrs)

A

preferred:
high-dose ICS + LABA + oral corticosteroid

alternative:
high-dose ICS + LTRA or theophylline + oral corticosteroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

intermittent asthma (>/= 12 yrs)

A

symptoms = 2 days/week
= 2 nighttime awakenings/month
SABA use = 2 days/week

22
Q

mild asthma (>/= 12 yrs)

A

symptoms > 2 days/week
3-4 nighttime awakenings/month
SABA use > 2 days/week (not daily)
minor normal activity limitation

23
Q

moderate asthma (>/= 12 yrs)

A

symptoms daily
> 1 nighttime awakening/week (not nightly)
SABA use daily
some normal activity limitation

24
Q

severe asthma (>/= 12 yrs)

A

symptoms throughout the day
nighttime awakenings often (7/week)
SABA use several times/day
extreme normal activity limitation

25
Q

step 1 therapy (>/= 12 yrs)

26
Q

step 2 therapy (>/= 12 yrs)

A

preferred:
low-dose ICS

alternative:
cromolyn, nedocromil, LTRA, or theophylline

27
Q

step 3 therapy (>/= 12 yrs)

A

preferred:
medium-dose ICS
OR
low-dose ICS + LABA

alternative:
low-dose ICS + LTRA, theophylline or zileuton

28
Q

step 4 therapy (>/= 12 yrs)

A

preferred:
medium-dose ICS + LABA

alternative:
medium-dose ICS + LTRA, theophylline, or zileuton

29
Q

step 5 therapy (>/= 12 yrs)

A

high-dose ICS + LABA
AND
omalizumab (pts w/ allergies)

30
Q

step 6 therapy (>/= 12 yrs)

A

high-dose ICS + LABA + oral corticosteroid
AND
omalizumab (pts w/ allergies)

31
Q

name the SABAs

A 
albuterol
levalbuterol
pirbuterol
metaproterenol
terbutaline
32
Q

brand names for albuterol

A

Ventolin
Proventil
ProAir HFA
ProAir Respiclick

33
Q

brand names for levalbuterol

34
Q

brand names for pirbuterol

A

Maxair

Autohaler

35
Q

brand names for metaproterenol

A

Alupent (D/c)

36
Q

brand names for terbutaline

37
Q

name the ICSs

A 
beclomethasone
budesonide
ciclesonide
flunisolide
fluticasone
mometasone
38
Q

brand names for beclomethasone

39
Q

brand names for budesonide

A

Pulmicort Flexhaler/Respules

40
Q

brand names for ciclesonide

41
Q

brand names for flunisolide

42
Q

brand names for fluticasone

43
Q

brand names for mometasone

44
Q

dosing for ICSs

A 
beclomethasone 40/80 mcg
budesonide 90 - 200 mcg
ciclesonide 80/160 mcg
flunisolide 80 mcg
fluticasone 44-220 mcg
mometasone 110/220 mcg
45
Q

ICS that is not BID

A

mometasone

46
Q

mast cell stabilizers

A

cromolyn

nedocromil

47
Q

brand name for cromolyn

48
Q

brand name for nedocromil

49
Q

LTRAs

A

montelukast

zafirlukast

50
Q

brand name for montelukast

51
Q

brand name for zafirlukast

52
Q

methylxanthines

A

theophylline

aminophylline

Pharmacotherapeutics III (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions